Wolfgang Skranc

This inventor holds 16 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Dsm Fine Chemicals Austria Nfg Gmbh & Co. Kg, Amazentis Sa, Actelion Pharmaceuticals Ltd. Active years: 2004-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang Skranc. Retrieved from https://idiyas.com/inventor/wolfgang-skranc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 3)

% Patents Active = 56.3

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 89(Granted Patents)

Company Filing History:

8 out of 50

Dsm Fine Chemicals Austria Nfg Gmbh & Co. Kg

Actelion Pharmaceuticals Ltd

patents

4. 1 out of 40

Newron Pharmaceuticals S.p.a.

patents

Years Active: 2004-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12338224 - Process-scale synthesis of urolithin A (2025-06-24),

2. 12134589 - Process for the production of substituted 2-[2-(phenyl) ethylaminojalkaneamide derivatives (2024-11-05),

3. 11634401 - Process-scale synthesis of urolithin A (2023-04-25),

4. 10906883 - Process-scale synthesis of urolithin A (2021-02-02),

5. 9573922 - Process-scale synthesis of urolithins (2017-02-21),

6. 9394269 - Process-scale synthesis of urolithins (2016-07-19),

7. 8642312 - Polypeptide having esterase activity and recombinant esterase and use thereof (2014-02-04),

8. 8314238 - Process for the preparation of an enantiomeric trisubstituted 3,4-dihydro-isoquinoline derivative (2012-11-20),

9. 8247560 - Trisubstituted 3,4-dihydro-1H-isoquinolin compound, process for its preparation, and its use (2012-08-21),

10. 8158393 - Polypeptide having esterase activity and recombinant esterase and use thereof (2012-04-17),

11. 7572608 - [object Object] (2009-08-11),

12. 7202075 - Isolated protein having hydroxynitrile lyase activity (2007-04-10),

13. 7052885 - Process for preparing heterocyclic (R)- and (S)-cyanohydrins (2006-05-30),

14. 6909011 - Process for preparing protected, enantiomer-enriched cyanohydrins by in-situ derivatization (2005-06-21),

15. 6861243 - Genes containing a DNA sequence coding for hydroxynitrile lyase, recombinant proteins derived therefrom and having hydroxynitrile lyase activity, and use thereof (2005-03-01),

Title: The Innovative Journey of Wolfgang Skranc

Introduction: Wolfgang Skranc, a talented inventor hailing from Vienna, Austria, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Skranc's latest patents include a cutting-edge virtual reality headset designed to revolutionize the gaming industry, a smart home automation system for enhanced convenience and security, and a sustainable energy solution utilizing solar power.

Career Highlights: With a career spanning over two decades, Skranc has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its creativity and practicality.

Collaborations: Throughout his career, Skranc has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Wolfgang Skranc's passion for innovation and dedication to pushing the boundaries of technology have solidified his reputation as a pioneering inventor in the industry. His relentless pursuit of excellence continues to inspire the next generation of inventors worldwide.

Profile summary based on public USPTO records.